RecruitingNot ApplicableNCT05822141

Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure

Omega-3 Fatty Acid Modulation of Brown Adipose Tissue for Arctic Resilience


Sponsor

Indiana University

Enrollment

30 participants

Start Date

Jun 12, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial will assess the whether fish oil supplementation can modulate brown fat activation, shivering, thermal comfort and skin blood flow during cold exposure.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study investigates whether omega-3 fatty acid supplementation can increase brown adipose tissue (BAT) activity during cold exposure. Brown fat is a special type of fat tissue that generates heat by burning calories — unlike white fat which just stores energy. In adults, BAT activity declines with age and is lower in people with obesity or metabolic disease. Cold exposure naturally activates BAT, and there is emerging evidence that omega-3 fatty acids (found in fish oil) may enhance this process. If true, this could offer a novel strategy to increase calorie burning and improve metabolic health. To be eligible, participants must be adults aged 18 to 40 with a healthy BMI (18.5–24.9), be moderately to highly active, and not have any significant medical conditions (cardiovascular disease, diabetes, renal disease, metabolic disorders, etc.). People who regularly consume fish oil or eat more than one fish meal per week, have bleeding disorders, take SSRIs, or have a resting blood pressure above 130/90 are excluded. Participants are randomized to receive omega-3 supplements or a placebo, then undergo controlled cold exposure sessions. Researchers measure BAT activity (using imaging) and metabolic rate before and after the intervention. This research matters because finding safe, accessible ways to activate BAT could provide a new approach to combating obesity and metabolic syndrome — without the side effects of drugs — and omega-3 supplementation is already widely used and well-tolerated.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTFish Oil

For 12 weeks subjects will ingest 6 capsules per day of fish oil (7.8 g/day total omega--3 fatty acids: 3.75 g/day EPA and 1.5 g/day DHA)

DIETARY_SUPPLEMENTPlacebo

For 12 weeks subjects will ingest 6 capsules per day of olive oil (each capsule contains 990 mg of olive oil)


Locations(1)

Human Perfromance Lab, Indiana University

Bloomington, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05822141


Related Trials